Informazioni su Precigen, Inc. - Common Stock Panoramica della società da Wikipedia

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.

Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.

Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

## History

In 2015, Intrexon purchased Oxitec, a maker of genetically sterile insects, for $160 million. In April 2019, Intrexon formed a subsidiary called Precigen, with a focus on human gene therapy. Precigen went on to win orphan drug status from the FDA for a CAR-T based therapy (investigational drug name PRGN-3006) to treat acute myeloid leukemia. In early 2020, Intrexon adopted the name of its subsidiary, Precigen, and narrowed its focus to human gene editing. With the change in name the CEO of subsidiary Precigen, Helen Sabzevari, took over leadership of the company from Randal J. Kirk.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

PGEN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$7.01

Capitalizzazione di Mercato

$2.49B

P/E (TTM)

-5.1

EPS (TTM)

$-1.37

Ricavi (TTM)

$10M

Rendimento div.

—

ROE

3159.1%

D/E Debito/Patrimonio

4.5

Intervallo 52 sett.

$3 – $7

PGEN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $10M

2016-12-31 → 2025-12-31

EPS $-1.37

2019-12-31 → 2025-12-31

Flusso di cassa libero $-90M

2016-12-31 → 2025-12-31

Margini -2588.2%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

PGEN

Mediana dei peer

P/E (TTM)

-5.1

55.4

P/S (TTM)

257.6

7.7

P/B

119.3

7.1

EV / EBITDA

-23.2

—

Price / FCF (Prezzo / FCF)

-27.8

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

PGEN

Mediana dei peer

Operating Margin (Margine Operativo)

-1141.1%

—

Net Profit Margin (Margine di Profitto Netto)

-2588.2%

-2.0%

ROA

-166.7%

-32.7%

ROE

3159.1%

-37.9%

ROIC

-96.9%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

PGEN

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

4.5

18.7

Current Ratio (Rapporto corrente)

3.1

7.4

Quick Ratio

2.7

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

PGEN

Mediana dei peer

Revenue YoY (Ricavi YoY)

146.7%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

-28.9%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

-21.3%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

PGEN

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-1.37

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

PGEN

Mediana dei peer

PGEN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 9 analisti

Acquisto forte 2 22,2%
Compra 5 55,6%
Mantieni 2 22,2%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

2 analisti · 2026-08-13

Mediana $14.50

← Sotto tutti i target $7.01

Basso $11.00

Alto $18.00

Target mediano $14.50 +106,8%

Target medio $14.50 +106,8%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

-0.12%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$0.05	$-0.01	0.06%
31 Marzo 2026	$-0.02	$-0.03	0.01%
31 Dicembre 2025	$-0.07	$-0.09	0.01%
30 Settembre 2025	$-1.06	$-0.10	-0.96%
30 Giugno 2025	$-0.09	$-0.08	-0.01%
31 Marzo 2025	$-0.07	$-0.08	0.01%
31 Dicembre 2024	$-0.06	$-0.06	-0.00%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
PGEN	$1.48B	-3.1	146.7%	-2588.2%	3159.1%	—
RARE	$2.22B	-3.9	20.2%	-85.4%	-1613.2%	—
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	—
COAG	—	—	—	—	—	—
KLRA	—	—	—	—	—	—
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	—
VERA	—	-10.9	—	—	-55.9%	—
MLYS	$2.96B	-15.8	—	—	-32.2%	—
VCEL	$1.82B	112.5	16.4%	6.0%	5.0%	74.4%
PVLA	$1.30B	-28.2	65.3%	-1610.6%	-110.1%	—
BHVN	$1.50B	-1.6	—	—	-310.8%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$10M	$4M	$6M	$27M	$14M	$32M	$91M	$151M	$231M	$191M	$174M	$72M
Cost of Revenue	·	·	·	·	·	·	·	·	$33M	$38M	$41M	$11M
R&D Expense	$41M	$53M	$49M	·	·	·	·	$405M	$143M	$112M	$147M	$59M
SG&A Expense	$70M	$41M	$40M	·	·	·	·	$138M	$146M	$142M	$109M	$64M
Operating Expenses	$120M	$139M	$106M	·	·	·	·	$666M	$369M	$316M	$320M	$142M
Operating Income	$-111M	$-135M	$-100M	·	·	·	·	$-506M	$-138M	$-125M	$-147M	$-70M
Interest Expense	·	·	·	·	·	·	·	$9M	$611.0K	$861.0K	$1M	$666.0K
Other Non-op	$43.0K	$6M	$627.0K	·	·	·	·	$630.0K	$1M	$2M	$1M	$-168.0K
Pretax Income	$-251M	$-128M	$-96M	$-80M	$-111M	$-105M	$-171M	$-396M	$-78M	$-194M	$-87M	$-86M
Income Tax	$3.0K	$-2M	$-458.0K	$-189.0K	$-160.0K	$-82.0K	$-930.0K	$-15M	$2M	$-4M	$1M	$-103.0K
Net Income	$-251M	$-126M	$-96M	$28M	$-92M	$-171M	$-322M	$-509M	$-117M	$-187M	$-84M	$-82M
EPS (Basic)	$-1.37	$-0.47	$-0.39	$0.14	$-0.47	$-1.02	$-2.09	·	·	·	·	·
EPS (Diluted)	$-1.37	$-0.47	$-0.39	$0.14	$-0.47	$-1.02	$-2.09	·	·	·	·	·
Shares (Basic)	312,980,562	267,727,426	244,536,221	200,360,821	197,759,900	167,065,539	154,138,774	·	·	·	·	·
Shares (Diluted)	312,980,562	267,727,426	244,536,221	200,360,821	197,759,900	167,065,539	154,138,774	·	·	·	·	·
EBITDA	$-107M	·	·	$11M	$14M	$18M	$25M	$-472M	$-107M	$-101M	·	$-60M

Stato Patrimoniale 27

Dati annuali Stato Patrimoniale per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$30M	$30M	$8M	$5M	$36M	$52M	$66M	$97M	$68M	$63M	$136M	$27M
Short-term Investments	$68M	$68M	$55M	$51M	$72M	$48M	$9M	$120M	$6M	$175M	$103M	$88M
Receivables	$4M	$926.0K	$902.0K	$978.0K	$1M	$16M	$21M	$21M	$20M	$22M	$25M	$15M
Prepaid Expense	$3M	$3M	$4M	$5M	$5M	$7M	$6M	$5M	$7M	$7M	$7M	$4M
Current Assets	$115M	$102M	$69M	$118M	$157M	$149M	$235M	$285M	$154M	$315M	$324M	$175M
PP&E (Net)	$14M	$14M	$7M	$7M	$9M	$35M	$44M	$87M	$113M	$65M	$43M	$38M
PP&E (Gross)	$38M	$37M	$31M	$31M	$30M	$70M	$80M	$136M	$158M	$99M	$69M	$60M
Accum. Depreciation	$24M	$23M	$24M	$23M	$21M	$35M	$36M	$49M	$46M	$34M	$26M	$22M
Goodwill	$15M	$19M	$27M	$37M	$38M	$54M	$54M	$94M	$94M	$157M	$165M	$101M
Intangibles	$3M	$4M	$41M	$44M	$52M	$65M	$68M	$89M	$233M	$226M	$248M	$66M
Other Non-current Assets	$908.0K	$371.0K	$767.0K	$1M	$936.0K	$2M	$1M	$2M	$4M	$4M	$4M	$1M
Total Assets	$156M	$145M	$151M	$216M	$360M	$315M	$456M	$716M	$847M	$949M	$982M	$576M
Accounts Payable	$12M	$4M	$2M	$4M	$3M	$5M	$6M	$12M	$9M	$8M	$5M	$6M
Short-term Debt	·	·	$0	$43M	·	·	·	·	·	·	·	·
Current Liabilities	$37M	$22M	$23M	$79M	$35M	$42M	$123M	$62M	$80M	$95M	$76M	$47M
Capital Leases	$4M	$5M	$6M	$7M	$9M	$8M	$10M	$0	·	·	·	·
Deferred Tax	·	$0	$2M	$2M	$3M	$3M	$3M	$4M	$16M	$17M	$22M	$0
Other Non-current Liabilities	$134.0K	$0	·	·	$50.0K	$100.0K	$0	$3M	$3M	$4M	$795.0K	$699.0K
Total Liabilities	$135M	$79M	$33M	$90M	$253M	$247M	$384M	$337M	$300M	$380M	$277M	$167M
Long-term Debt	$93M	$0	·	$43M	$180M	$172M	$218M	$212M	$8M	$8M	$9M	$10M
Total Debt	$93M	·	·	$43M	$183M	$172M	$218M	$212M	$8M	$8M	·	$10M
Paid-in Capital	$2.36B	$2.13B	$2.08B	$2.00B	$2.02B	$1.89B	$1.75B	$1.72B	$1.40B	$1.33B	$1.25B	$843M
Retained Earnings	$-2.34B	$-2.09B	$-1.96B	$-1.87B	$-1.92B	$-1.82B	$-1.65B	$-1.33B	$-848M	$-729M	$-543M	$-458M
AOCI	$7.0K	$12.0K	$-2M	$-3M	$203.0K	$4M	$-27M	$-29M	$-16M	$-36M	$-13M	$-4.0K
Stockholders' Equity	$21M	$39M	$118M	$126M	$107M	$67M	$72M	$363M	$534M	$560M	$694M	$385M
Liabilities + Equity	$156M	$145M	$151M	$216M	$360M	$315M	$456M	$716M	$847M	$949M	$982M	$576M
Shares Outstanding	353,910,926	292,869,097	248,919,096	208,150,021	206,739,874	187,663,207	163,274,880	160,020,466	122,087,040	118,688,770	116,658,886	100,557,932

Flusso di cassa 16

Dati annuali Flusso di cassa per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$3M	$5M	$7M	$11M	$14M	$18M	$25M	$33M	$31M	$25M	$18M	$10M
Stock-based Comp	$11M	$9M	$10M	$10M	$14M	$18M	$19M	$36M	$42M	$42M	$39M	$22M
Deferred Tax	$0	$-2M	$-479.0K	$-150.0K	$-167.0K	$-156.0K	$-4M	$-21M	$-3M	$-3M	$1M	$0
Amort. of Intangibles	$1M	$3M	$5M	$5M	$5M	$5M	$8M	$12M	$11M	$15M	$10M	$4M
Other Non-cash	$149M	·	·	$-114M	$9M	$58M	$146M	$337M	$-57M	$67M	·	$30M
Operating Cash Flow	$-88M	$-68M	$-67M	$-65M	$-56M	$-77M	$-136M	$-124M	$-104M	$-49M	$36M	$-20M
CapEx	$2M	$9M	$2M	$5M	$7M	$8M	$38M	$42M	$47M	$32M	$13M	$6M
Investing Cash Flow	$-2M	$-21M	$-3M	$226M	$-75M	$28M	$87M	$-151M	$104M	$-28M	$-259M	$-26M
Debt Issued	$93M	$0	$0	·	$0	$0	$376.0K	$220M	$325.0K	$547.0K	$81.0K	$268.0K
Net Debt Issued	$93M	·	·	$-155M	$-466.0K	$-490.0K	$-242.0K	$219M	$-194.0K	$-654.0K	·	$-379.0K
Stock Issued	$-355.0K	$31M	$73M	$0	·	·	·	·	$0	$0	$328M	$0
Net Stock Activity	$-355.0K	·	·	·	·	·	·	·	$0	$0	·	·
Financing Cash Flow	$90M	$111M	$30M	$-155M	$121M	$33M	$8M	$310M	$4M	$12M	$332M	$24M
Net Change in Cash	$717.0K	$22M	$-41M	$5M	$-9M	$-16M	$-42M	$35M	$6M	$-66M	$108M	$-22M
Free Cash Flow	$-90M	·	·	$-70M	$-63M	$-85M	$-174M	$-166M	$-151M	$-88M	·	$-26M
Levered FCF	·	·	·	·	·	·	·	$-174M	$-151M	$-88M	·	$-27M

Redditività 7

Dati annuali Redditività per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	-1141.1%	·	·	·	·	·	·	·	-59.7%	-65.6%	·	-97.3%
Net Margin	-2588.2%	·	·	105.2%	-88.7%	-165.3%	·	·	-50.7%	-97.7%	·	-113.8%
Pretax Margin	-2588.2%	·	·	-297.2%	-93.3%	-100.7%	·	·	-56.1%	-101.7%	·	-119.2%
EBITDA Margin	-1108.1%	·	·	40.0%	13.2%	17.0%	·	·	-46.2%	-52.7%	·	-82.8%
ROA	-166.7%	·	·	9.8%	-27.3%	-44.3%	-55.0%	-65.2%	-13.0%	-19.3%	·	-15.7%
ROE	3159.1%	·	·	21.1%	-77.3%	-271.3%	-148.3%	-113.6%	-21.4%	-29.8%	·	-21.8%
ROIC	-96.9%	·	·	·	·	·	·	-84.5%	-24.9%	-21.6%	·	-17.7%

Liquidità e Solvibilità 5

Dati annuali Liquidità e Solvibilità per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.1	·	·	1.5	4.5	3.5	1.9	4.6	1.9	3.3	·	3.7
Quick Ratio	2.7	·	·	0.7	3.9	2.8	0.8	4.0	1.2	2.7	·	2.7
Debt / Equity	4.5	·	·	0.3	1.7	2.6	3.0	0.6	0.0	0.0	·	0.0
LT Debt / Equity	4.5	·	·	0.0	1.7	2.6	2.6	0.6	0.0	0.0	·	0.0
Interest Coverage	·	·	·	·	·	·	·	-59.3	-225.7	-145.4	·	-105.0

Efficienza 2

Dati annuali Efficienza per PGEN
Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover		0.1	·	·	0.1	0.3	0.3	·	·	0.3	0.2	·	0.1
Receivables Turnover		4.0	·	·	23.4	5.6	5.6	·	·	11.2	8.2	·	9.4

Per Azione 5

Dati annuali Per Azione per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$0.06	·	·	$0.61	$0.52	$0.36	$0.44	$2.27	$4.37	$4.72	·	$3.83
Revenue / Share	$0.03	·	·	$0.13	$0.53	·	·	·	·	·	·	·
Cash Flow / Share	$-0.28	·	·	$-0.32	$-0.28	·	·	·	·	·	·	·
Cash / Share	$0.09	·	·	$0.02	$0.21	$0.28	$0.40	$0.64	$0.56	$0.53	·	$0.27
EPS (TTM)	$-1.37	$-0.47	$-0.39	$0.14	$-0.47	$-1.02	$-2.09	$-1.54	$-1.54	$-1.54	$-0.74	$-0.84

Tassi di Crescita 3

Dati annuali Tassi di Crescita per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	146.7%	-37.0%	-76.9%	88.6%	-55.4%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-28.9%	-35.0%	-42.0%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-21.3%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per PGEN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$10M	$4M	$6M	$27M	$14M	$32M	$91M	$151M	$231M	$191M	$174M	$72M
Net Income TTM	$-251M	$-126M	$-96M	$28M	$-92M	$-171M	$-322M	$-509M	$-117M	$-187M	$-84M	$-82M
Market Cap	$1.48B	·	·	$316M	$767M	$1.91B	$895M	$1.05B	$1.41B	$2.86B	·	$2.65B
Enterprise Value	$1.47B	·	·	$304M	$835M	$1.99B	$1.04B	$1.04B	$1.34B	$2.63B	·	$2.54B
P/E	-3.1	-2.4	-3.4	10.9	-7.9	-10.0	-2.6	-4.2	-7.5	-15.6	-40.4	-31.3
P/S	152.8	·	·	11.8	53.8	59.8	9.9	6.9	6.1	15.0	·	36.8
P/B	70.7	·	·	2.5	7.1	28.5	12.5	2.9	2.6	5.1	·	6.9
P / Tangible Book	592.5	8.0	6.5	7.0	43.8	·	·	·	·	·	·	·
P / Cash Flow	-16.8	·	·	-4.9	-13.8	-24.9	-6.6	-8.4	-13.5	-51.1	·	-133.2
P / FCF	-16.5	·	·	-4.5	-12.2	-22.6	-5.1	-6.3	-9.3	-32.6	·	-100.9
EV / EBITDA	-13.7	·	·	28.2	60.7	113.4	41.7	-2.2	-12.6	-26.1	·	-42.7
EV / FCF	-16.4	·	·	-4.3	-13.3	-23.5	-6.0	-6.2	-8.9	-30.0	·	-96.8
EV / Revenue	152.3	·	·	11.3	58.5	62.1	11.4	6.9	5.8	13.8	·	35.3
Earnings Yield	-32.8%	-42.0%	-29.1%	9.2%	-12.7%	-10.0%	-38.1%	-23.5%	-13.4%	-6.4%	-2.5%	-3.2%

Conto Economico 14

Dati trimestrali Conto Economico per PGEN
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$55M	$23M	·	·	$856.0K	$1M	·	·	·	·	·	·	$2M	$2M	·	$17M
R&D Expense	$7M	$6M	·	·	$11M	$10M	·	·	·	·	·	·	·	·	·	·
SG&A Expense	$22M	$21M	·	·	$16M	$12M	·	·	·	·	·	·	·	·	·	·
Operating Expenses	$32M	$29M	·	·	$33M	$24M	·	·	·	·	·	·	·	·	·	·
Operating Income	$23M	$-6M	·	·	$-32M	$-23M	·	·	·	·	·	·	·	·	·	·
Other Non-op	$16.0K	$290.0K	·	·	$-31.0K	$7.0K	·	·	·	·	·	·	·	·	·	·
Pretax Income	$20M	$-8M	·	·	$-27M	$-54M	$-20M	$-24M	$-60M	$-24M	$-33M	$-20M	$-20M	$-23M	$-22M	$-8M
Income Tax	$0	$0	$0	$0	$3.0K	$0	$-87.0K	$12.0K	$-2M	$-29.0K	$-332.0K	$-6.0K	$-65.0K	$-55.0K	$8.0K	$-50.0K
Net Income	$20M	$-8M	$-24M	$-146M	$-27M	$-54M	$-20M	$-24M	$-59M	$-24M	$-33M	$-20M	$-20M	$-23M	$-22M	$87M
EPS (Basic)	$0.06	$-0.02	$-0.04	$-1.06	$-0.09	$-0.18	$-0.05	$-0.09	$-0.23	$-0.10	$-0.13	$-0.08	$-0.08	$-0.10	$-0.11	$0.44
EPS (Diluted)	$0.05	$-0.02	$-0.04	$-1.06	$-0.09	$-0.18	$-0.05	$-0.09	$-0.23	$-0.10	$-0.13	$-0.08	$-0.08	$-0.10	$-0.11	$0.44
Shares (Basic)	356,893,568	354,291,007	-584,504,307	307,170,490	296,434,726	293,879,653	-509,740,612	275,881,170	252,366,533	249,220,335	-481,758,206	248,520,724	248,003,322	229,770,381	-400,400,428	200,670,590
Shares (Diluted)	413,686,865	354,291,007	-584,504,307	307,170,490	296,434,726	293,879,653	-509,740,612	275,881,170	252,366,533	249,220,335	-481,758,206	248,520,724	248,003,322	229,770,381	-400,400,428	200,670,590
EBITDA	$23M	$-5M	·	·	·	$629.0K	·	·	·	$2M	·	·	·	$2M	·	·

Stato Patrimoniale 27

Dati trimestrali Stato Patrimoniale per PGEN
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$16M	$7M	$30M	$14M	$14M	$6M	$30M	$25M	$9M	$17M	·	$10M	$17M	$10M	·	$9M
Short-term Investments	$22M	$49M	$68M	$107M	$46M	$74M	$68M	$4M	$10M	$27M	·	$64M	$72M	$94M	·	$62M
Receivables	$72M	$26M	$4M	$580.0K	$327.0K	$751.0K	$926.0K	$479.0K	$511.0K	$872.0K	·	$988.0K	$1M	$2M	·	$1M
Prepaid Expense	$4M	$4M	$3M	$4M	$2M	$3M	$3M	$5M	$3M	$4M	·	$5M	$3M	$4M	·	$6M
Current Assets	$134M	$102M	$115M	$130M	$63M	$85M	$102M	$35M	$24M	$50M	·	$93M	$106M	$138M	·	$163M
PP&E (Net)	$13M	$13M	$14M	$15M	$15M	$15M	$14M	$14M	$13M	$13M	·	$7M	$7M	$7M	·	$8M
PP&E (Gross)	$38M	$38M	$38M	$38M	$37M	$38M	$37M	$36M	$36M	$37M	·	$31M	$31M	$31M	·	$30M
Accum. Depreciation	$25M	$25M	$24M	$23M	$23M	$23M	$23M	$23M	$22M	$25M	·	$24M	$24M	$24M	·	$23M
Goodwill	$15M	$15M	$15M	$15M	$15M	$19M	$19M	$25M	$25M	$27M	$27M	$37M	$37M	$37M	$37M	$37M
Intangibles	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$5M	$5M	$39M	·	$40M	$43M	$44M	·	$42M
Other Non-current Assets	$708.0K	$782.0K	$908.0K	$753.0K	$590.0K	$427.0K	$371.0K	$425.0K	$435.0K	$751.0K	·	$797.0K	$949.0K	$1M	·	$871.0K
Total Assets	$170M	$139M	$156M	$171M	$102M	$129M	$145M	$83M	$73M	$135M	·	$191M	$208M	$242M	·	$259M
Accounts Payable	$5M	$3M	$12M	$6M	$4M	$3M	$4M	$4M	$5M	$5M	·	$2M	$3M	$4M	·	$4M
Short-term Debt	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$14M	·	·
Current Liabilities	$29M	$21M	$37M	$32M	$23M	$24M	$22M	$21M	$23M	$29M	·	$33M	$31M	$47M	·	$105M
Capital Leases	$3M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	·	$6M	$7M	$7M	·	$8M
Deferred Tax	·	·	·	·	·	·	·	$89.0K	$77.0K	$2M	·	$2M	$2M	$2M	·	$2M
Other Non-current Liabilities	$77.0K	$106.0K	$134.0K	$163.0K	·	·	$0	·	·	·	·	·	·	·	·	·
Total Liabilities	$127M	$118M	$135M	$129M	$108M	$113M	$79M	$28M	$30M	$38M	·	$43M	$41M	$57M	·	$117M
Long-term Debt	$94M	$94M	$93M	$93M	·	·	$0	·	·	·	·	·	·	·	·	$82M
Total Debt	$94M	$94M	·	·	·	·	·	·	·	·	·	$0	$0	$14M	·	$82M
Paid-in Capital	$2.37B	$2.37B	$2.36B	$2.36B	$2.13B	$2.13B	$2.13B	$2.13B	$2.09B	$2.09B	·	$2.08B	$2.08B	$2.08B	·	$2.00B
Retained Earnings	$-2.33B	$-2.35B	$-2.34B	$-2.32B	$-2.17B	$-2.14B	$-2.09B	$-2.07B	$-2.05B	$-1.99B	·	$-1.93B	$-1.91B	$-1.89B	·	$-1.85B
AOCI	$-29.0K	$-17.0K	$7.0K	$24.0K	$11.0K	$12.0K	$12.0K	$13.0K	$-3M	$-3M	·	$-4M	$-3M	$-3M	·	$-7M
Stockholders' Equity	$44M	$20M	$21M	$42M	$-37M	$-14M	$39M	$55M	$43M	$97M	$118M	$148M	$166M	$184M	$126M	$143M
Liabilities + Equity	$170M	$139M	$156M	$171M	$102M	$129M	$145M	$83M	$73M	$135M	·	$191M	$208M	$242M	·	$259M
Shares Outstanding	358,008,798	355,903,977	353,910,926	353,810,556	297,846,160	295,135,060	292,869,097	292,869,097	252,656,151	250,248,808	248,919,096	256,398,527	255,482,753	255,482,753	208,150,021	208,150,021

Flusso di cassa 15

Dati trimestrali Flusso di cassa per PGEN
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$1M	$1M	$1M	$803.0K	$630.0K	$629.0K	$661.0K	$674.0K	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$3M
Stock-based Comp	$4M	$3M	$2M	$4M	$2M	$3M	$3M	$2M	$2M	$3M	$2M	$2M	$2M	$3M	$2M	$2M
Deferred Tax	·	·	$0	$0	$0	$0	$-89.0K	$12.0K	$-2M	$-29.0K	$-353.0K	$-13.0K	$-58.0K	$-55.0K	$12.0K	$-50.0K
Amort. of Intangibles	$319.0K	$318.0K	$318.0K	$318.0K	$318.0K	$319.0K	$318.0K	$318.0K	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M
Other Non-cash	·	$-40M	·	·	·	$35M	·	·	·	$6M	·	·	·	$-441.0K	·	·
Operating Cash Flow	$-18M	$-44M	$-23M	$-29M	$-19M	$-16M	$-8M	$-23M	$-23M	$-14M	$-16M	$-17M	$-16M	$-18M	$-15M	$-24M
CapEx	$392.0K	$258.0K	$18.0K	$389.0K	$966.0K	$622.0K	$1M	$882.0K	$2M	$4M	$1M	$236.0K	$101.0K	$154.0K	$53.0K	$2M
Investing Cash Flow	$27M	$21M	$40M	$-63M	$28M	$-6M	$-65M	$6M	$15M	$24M	$13M	$11M	$24M	$-50M	$11M	$182M
Debt Issued	·	·	$-654.0K	·	·	·	$0	·	·	·	·	·	·	·	·	·
Net Debt Issued	·	·	·	·	·	·	·	·	·	$0	·	·	·	$-29M	·	·
Stock Issued	$0	$0	$0	$0	$0	$-355.0K	$-596.0K	$32M	$0	$0	$0	$0	$-693.0K	$74M	$0	$0
Net Stock Activity	·	$0	·	·	·	$-355.0K	·	·	·	$0	·	·	·	$74M	·	·
Financing Cash Flow	$-33.0K	$109.0K	$-514.0K	$93M	$-2M	$-679.0K	$78M	$32M	$52.0K	$0	$0	$0	$-15M	$44M	$-39M	$-116M
Net Change in Cash	$9M	$-23M	$16M	$562.0K	$8M	$-23M	$5M	$15M	$-8M	$10M	$-2M	$-7M	$-7M	$-25M	$-43M	$42M
Free Cash Flow	·	$-44M	·	·	·	$-17M	·	·	·	$-18M	·	·	·	$-19M	·	·

Redditività 7

Dati trimestrali Redditività per PGEN
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	41.2%	-25.8%	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Net Margin	36.5%	-34.1%	·	·	·	·	·	·	·	·	·	·	-1149.9%	-1228.2%	·	522.5%
Pretax Margin	36.5%	-34.1%	·	·	·	·	·	·	·	·	·	·	-1153.6%	-1231.2%	·	-46.0%
EBITDA Margin	41.2%	-21.1%	·	·	·	·	·	·	·	·	·	·	·	92.4%	·	·
ROA	14.8%	-5.9%	·	-114.9%	-30.4%	-41.1%	·	-17.5%	-41.9%	-12.6%	·	-8.8%	-7.7%	-7.9%	·	27.5%
ROE	590.6%	-256.8%	·	-301.0%	-833.7%	-130.6%	·	-23.6%	-56.2%	-16.9%	·	-13.6%	-18.3%	-17.6%	·	63.8%
ROIC	16.5%	-5.3%	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Liquidità e Solvibilità 4

Dati trimestrali Liquidità e Solvibilità per PGEN
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.6	4.8	·	4.0	2.7	3.5	·	1.6	1.0	1.7	·	2.8	3.4	2.9	·	1.6
Quick Ratio	3.8	3.9	·	3.8	2.6	3.4	·	1.4	0.9	1.6	·	2.3	2.9	2.3	·	0.7
Debt / Equity	2.2	4.6	·	·	·	·	·	·	·	·	·	0.0	0.0	0.1	·	0.6
LT Debt / Equity	2.2	4.6	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0

Efficienza 2

Dati trimestrali Efficienza per PGEN
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.4	0.2	·	·	·	·	·	·	·	·	·	·	0.0	0.0	·	0.1
Receivables Turnover		1.5	1.7	·	·	·	·	·	·	·	·	·	·	1.3	0.1	·	1.6

Per Azione 5

Dati trimestrali Per Azione per PGEN
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.12	$0.06	·	$0.12	$-0.12	$-0.05	·	$0.19	$0.17	$0.39	·	$0.58	$0.65	$0.72	·	$0.68
Revenue / Share	$0.13	$0.07	·	·	·	·	·	·	·	·	·	·	$0.01	$0.01	·	$0.08
Cash Flow / Share	·	$-0.12	·	·	·	$-0.06	·	·	·	$-0.06	·	·	·	$-0.08	·	·
Cash / Share	$0.05	$0.02	·	$0.04	$0.05	$0.02	·	$0.08	$0.04	$0.07	·	$0.04	$0.06	$0.04	·	$0.04
EPS (TTM)	$-1.12	$-1.35	·	$-1.42	$-0.59	$-0.60	·	$-0.50	$-0.49	$-0.36	·	$0.18	$0.17	$0.15	·	$0.10

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per PGEN
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	·	·	·	$23M	$23M	$23M	·	$23M	$23M	$23M	·	$23M	$23M	$27M	·	$28M
Net Income TTM	$-161M	$-235M	·	$-251M	$-164M	$-161M	·	$-126M	$-123M	$-87M	·	$25M	$27M	$28M	·	$21M
Market Cap	$2.04B	$1.38B	·	$1.16B	$423M	$440M	·	$278M	$399M	$363M	·	$364M	$294M	$271M	·	$441M
Enterprise Value	$2.10B	$1.41B	·	·	·	·	·	·	·	·	·	$290M	$205M	$181M	·	$452M
P/E	-5.1	-2.9	·	-2.3	-2.4	-2.5	·	-1.9	-3.2	-4.0	·	7.9	6.8	7.1	·	21.2
P/S	·	·	·	50.1	18.2	18.9	·	12.0	17.2	15.6	·	15.7	12.6	10.0	·	15.5
P/B	46.8	68.1	·	27.8	-11.5	-31.3	·	5.0	9.2	3.7	·	2.5	1.8	1.5	·	3.1
P / Tangible Book	79.1	643.9	·	50.3	·	·	·	10.8	30.3	11.4	·	5.2	3.4	2.6	·	7.0
P / Cash Flow	·	-31.4	·	·	·	-26.9	·	·	·	-25.8	·	·	·	-14.7	·	·
P / FCF	·	-31.2	·	·	·	-25.9	·	·	·	-19.7	·	·	·	-14.6	·	·
EV / EBITDA	92.6	-289.0	·	·	·	·	·	·	·	·	·	·	·	105.5	·	·
EV / FCF	·	-32.1	·	·	·	·	·	·	·	·	·	·	·	-9.7	·	·
EV / Revenue	·	·	·	·	·	·	·	·	·	·	·	12.5	8.8	6.7	·	15.9
Earnings Yield	-19.7%	-34.9%	·	-43.2%	-41.5%	-40.3%	·	-52.6%	-31.0%	-24.8%	·	12.7%	14.8%	14.1%	·	4.7%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$10M	$4M	$6M	$27M	$14M
Margine Operativo %	-1141.1%	—	—	—	—
Utile netto	$-251M	$-126M	$-96M	$28M	$-92M
EPS Diluito	$-1.37	$-0.47	$-0.39	$0.14	$-0.47

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	4.5	—	—	0.3	1.7
Rapporto corrente	3.1	—	—	1.5	4.5
Quick Ratio	2.7	—	—	0.7	3.9

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-90M	—	—	$-70M	$-63M

Ultime notizie Notizie recenti che menzionano questa società

Precigen Inc. (PGEN) è la migliore penny stock sanitaria da acquistare? Yahoo Finance · 4 mesi fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 234 filer · $661.7M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
47 (+4 vs trimestre precedente)	26 (+9 vs trimestre precedente)	74 (+6 vs trimestre precedente)	49 (+2 vs trimestre precedente)	+19.0M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
Patient Capital Management, LLC	$108.510.760	19.036.976	16,40%	Azioni
STATE STREET CORP	$68.414.051	12.002.465	10,34%	Azioni
Diametric Capital, LP	$52.838.578	9.269.926	7,98%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$45.065.112	7.906.160	6,81%	Azioni
TANG CAPITAL MANAGEMENT LLC	$36.579.750	6.417.500	5,53%	Azioni
Boxer Capital Management, LLC	$29.355.000	5.150.000	4,44%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$24.765.144	4.343.981	3,74%	Azioni
IRIDIAN ASSET MANAGEMENT LLC/CT	$22.982.189	4.031.963	3,47%	Azioni
Occam Crest Management LP	$19.652.378	3.605.941	2,97%	Azioni
GOLDMAN SACHS GROUP INC	$17.290.013	3.033.336	2,61%	Azioni
FMR LLC	$14.640.068	2.568.433	2,21%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$12.603.680	2.211.172	1,90%	Azioni
MORGAN STANLEY	$12.563.991	2.204.209	1,90%	Azioni
FIRST TRUST ADVISORS LP	$11.483.556	2.014.659	1,74%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$10.192.940	1.788.235	1,54%	Azioni
Caption Management, LLC	$9.690.000	1.700.000	1,46%	Opzione Put
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$8.640.362	1.515.853	1,31%	Azioni
Diametric Capital, LP	$8.048.400	1.412.000	1,22%	Opzione Call
Woodline Partners LP	$7.991.087	1.401.945	1,21%	Azioni
VANGUARD FIDUCIARY TRUST CO	$7.386.904	1.295.948	1,12%	Azioni
Point72 Asset Management, L.P.	$7.220.070	1.266.679	1,09%	Azioni
Caption Management, LLC	$5.130.000	900.000	0,78%	Azioni
PRELUDE CAPITAL MANAGEMENT, LLC	$5.028.922	882.267	0,76%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$5.023.410	881.300	0,76%	Opzione Call
VANGUARD GROUP INC	$4.949.421	1.184.072	0,75%	Azioni
CITADEL ADVISORS LLC	$4.676.217	820.389	0,71%	Azioni
CITIGROUP INC	$4.068.341	713.744	0,61%	Azioni
ESSEX INVESTMENT MANAGEMENT CO LLC	$4.025.876	706.294	0,61%	Azioni
GMT Capital Corp	$3.812.331	668.830	0,58%	Azioni
LexAurum Advisors, LLC	$3.638.954	638.413	0,55%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$3.450.210	605.300	0,52%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.430.511	601.844	0,52%	Azioni
BANK OF AMERICA CORP /DE/	$3.030.816	531.722	0,46%	Azioni
Lansing Street Advisors	$2.823.905	495.422	0,43%	Azioni
BARCLAYS PLC	$2.806.687	492.401	0,42%	Azioni
CIBC Bancorp USA Inc.	$2.788.736	489.252	0,42%	Azioni
Swiss National Bank	$2.226.420	390.600	0,34%	Azioni
Cetera Investment Advisers	$2.209.947	387.710	0,33%	Azioni
LOS ANGELES CAPITAL MANAGEMENT LLC	$2.175.222	381.618	0,33%	Azioni
PEAK6 LLC	$2.100.450	368.500	0,32%	Opzione Call
Squarepoint Ops LLC	$2.013.650	353.272	0,30%	Azioni
Corient Private Wealth LP	$1.908.373	334.802	0,29%	Azioni
ExodusPoint Capital Management, LP	$1.778.001	311.930	0,27%	Azioni
JANE STREET GROUP, LLC	$1.572.060	275.800	0,24%	Opzione Call
Virtus Investment Advisers, LLC	$1.489.535	261.322	0,23%	Azioni
SIMPLEX TRADING, LLC	$1.419.339	249.007	0,21%	Azioni
RHUMBLINE ADVISERS	$1.347.743	236.448	0,20%	Azioni
BlackRock, Inc.	$1.337.271	234.609	0,20%	Azioni
ALPINE WOODS CAPITAL INVESTORS, LLC	$1.308.823	229.618	0,20%	Azioni
LPL Financial LLC	$1.302.518	228.512	0,20%	Azioni
STATE OF WISCONSIN INVESTMENT BOARD	$1.132.385	198.664	0,17%	Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$1.122.687	290.100	0,17%	Azioni
Rafferty Asset Management, LLC	$1.122.626	196.952	0,17%	Azioni
Shay Capital LLC	$1.083.000	190.000	0,16%	Azioni
WELLS FARGO & COMPANY/MN	$1.003.975	176.136	0,15%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$1.003.952	176.132	0,15%	Azioni
VICTORY CAPITAL MANAGEMENT INC	$964.275	169.171	0,15%	Azioni
OSAIC HOLDINGS, INC.	$902.052	158.257	0,14%	Azioni
VANGUARD ASSET MANAGEMENT, Ltd	$891.999	156.491	0,13%	Azioni
Pathstone Holdings, LLC	$891.349	156.377	0,13%	Azioni
ALLIANCEBERNSTEIN L.P.	$877.631	226.778	0,13%	Azioni
CITADEL ADVISORS LLC	$869.250	152.500	0,13%	Opzione Call
CIBC Private Wealth Group LLC	$847.060	257.465	0,13%	Azioni
Voleon Capital Management LP	$808.836	141.901	0,12%	Azioni
GLR Partners, LLC	$798.963	140.169	0,12%	Azioni
TWO SIGMA INVESTMENTS, LP	$780.729	136.970	0,12%	Azioni
DIADEMA PARTNERS LP	$771.170	135.293	0,12%	Azioni
Bank of New York Mellon Corp	$756.937	132.796	0,11%	Azioni
Aquatic Capital Management LLC	$698.336	122.515	0,11%	Azioni
Shay Capital LLC	$684.000	120.000	0,10%	Opzione Call
Vanguard Global Advisers, LLC	$672.104	117.913	0,10%	Azioni
AXQ CAPITAL, LP	$666.775	116.978	0,10%	Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$662.501	171.189	0,10%	Azioni
PRUDENTIAL FINANCIAL INC	$661.029	115.970	0,10%	Azioni
MetLife Investment Management, LLC	$643.638	112.919	0,10%	Azioni
Investment Insight Wealth Management, LLC	$603.009	105.791	0,09%	Azioni
Mill Creek Capital Advisors, LLC	$581.081	150.150	0,09%	Azioni
MILLENNIUM MANAGEMENT LLC	$574.976	100.873	0,09%	Azioni
US BANCORP \DE\	$570.000	100.000	0,09%	Azioni
PROFUND ADVISORS LLC	$568.877	99.803	0,09%	Azioni
HighTower Advisors, LLC	$554.279	97.242	0,08%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$519.253	91.097	0,08%	Azioni
Integrated Quantitative Investments LLC	$516.734	90.655	0,08%	Azioni
CARY STREET PARTNERS FINANCIAL LLC	$499.280	87.593	0,08%	Azioni
Invesco Ltd.	$438.330	76.900	0,07%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$414.390	72.700	0,06%	Opzione Put
CITADEL ADVISORS LLC	$412.110	72.300	0,06%	Opzione Put
AMERICAN FINANCIAL GROUP INC	$376.850	66.114	0,06%	Azioni
State of New Jersey Common Pension Fund D	$358.769	62.942	0,05%	Azioni
HAP Trading, LLC	$350.625	412.500	0,05%	Opzione Call
JANUS HENDERSON GROUP PLC	$343.985	89.000	0,05%	Azioni
China Universal Asset Management Co., Ltd.	$323.412	56.739	0,05%	Azioni
Cubist Systematic Strategies, LLC	$320.775	97.500	0,05%	Opzione Call
Mitsubishi UFJ Asset Management Co., Ltd.	$306.848	53.833	0,05%	Azioni
ARIZONA STATE RETIREMENT SYSTEM	$306.164	53.713	0,05%	Azioni
TWO SIGMA ADVISERS, LP	$305.558	73.100	0,05%	Azioni
Russell Investments Group, Ltd.	$304.277	53.382	0,05%	Azioni
Police & Firemen's Retirement System of New Jersey	$303.046	53.166	0,05%	Azioni
Pinnacle Financial Partners, Inc.	$300.903	52.790	0,05%	Azioni
ENVESTNET ASSET MANAGEMENT INC	$300.749	52.763	0,05%	Azioni

Insider aziendali 37 insider · 12 dirigenti · 10 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Helen Sabzevari	President and CEO	29 Giugno 2026 M	3.768.872	0	2	$-2.562.794
Harry Thomasian Jr.	Chief Financial Officer	31 Luglio 2026 S	254.535	2	4	$-1.861.741
Rick L. Sterling	Chief Financial Officer	04 Gennaio 2021 M	340.020	0	0	$0
Thomas Bostick	Chief Operating Officer	04 Gennaio 2020 M	74.280	0	0	$0
Phil Tennant	Chief Commercial Officer	28 Maggio 2026 S	139.369	1	1	$-110.506
Donald P. Lehr	Chief Legal Officer	28 Maggio 2026 S	755.461	0	1	$-127.011
Jeffrey Thomas Perez	SVP, IP Affairs	09 Agosto 2024 P	743.097	0	0	$0
Bradford D. Osborne	VP, Finance and Accounting	21 Aprile 2021 A	—	0	0	$0
Thomas D. Reed	Chief Science Officer	04 Gennaio 2020 M	148.888	0	0	$0
Robert F. Walsh III	SVP, Energy & Fine Chem.	30 Giugno 2019 M	28.816	0	0	$0
Nir Nimrodi	Chief Business Officer	04 Gennaio 2019 A	19.482	0	0	$0
Joel D Liffman	SVP, Finance	04 Gennaio 2019 A	99.315	0	0	$0
RANDAL J. KIRK	Direttore	30 Marzo 2026 S	12.262.741	0	28	$-60.808.573
Vinita D Gupta	Direttore	13 Marzo 2026 M	666.027	0	0	$0
Steven Frank	Direttore	13 Marzo 2026 M	1.226.391	0	0	$0
James S Turley	Direttore	13 Marzo 2026 M	685.417	0	0	$0
Nancy H Agee	Direttore	13 Marzo 2026 M	305.776	3	0	$167.651
Cesar L Alvarez	Direttore	13 Marzo 2026 M	782.909	0	0	$0
Jeffrey B Kindler	Direttore	13 Marzo 2026 M	202.100	0	3	$-1.458.937
Fred Hassan	Direttore	13 Marzo 2026 M	1.243.239	0	0	$0
Dean J Mitchell	Direttore	14 Marzo 2024 A	503.183	0	0	$0
Robert B Shapiro	Direttore	09 Marzo 2023 A	329.656	0	0	$0
Trading S.A. Ares	Proprietario del 10%	13 Ottobre 2021 S	20.647.152	0	0	$0
Rutul R Shah	—	06 Agosto 2026 S	465.012	1	4	$-874.598
Andrew J. Last	—	13 Novembre 2017 P	4.000	0	0	$0
Geno J Germano	—	22 Settembre 2016 A	—	0	0	$0
Suma Krishnan	—	29 Gennaio 2016 M	56.657	0	0	$0
Krish S Krishnan	—	29 Gennaio 2016 M	56.657	0	0	$0
Ena Chan Cratsenburg	—	07 Gennaio 2016 A	—	0	0	$0
INTREXON CORP	—	07 Gennaio 2016 A	—	0	0	$0
Joseph L Vaillancourt	—	19 Ottobre 2015 A	—	0	0	$0
Corey Huck	—	12 Ottobre 2015 A	—	0	0	$0
Samuel Broder	—	21 Luglio 2015 A	—	0	0	$0
Jack A Bobo	—	20 Luglio 2015 A	—	0	0	$0
Olivier Roger Jarry	—	11 Giugno 2015 A	—	0	0	$0
Gregory Ian Frost	—	28 Maggio 2015 M	300.000	0	0	$0
HORNER LARRY D /FA	—	12 Marzo 2015 A	68.507	0	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 3 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
RANDAL J. KIRK, R.J. KIRK DECLARATION OF TRUST, THIRD SECURITY, LLC ×21 depositi	31 Marzo 2026	35,90%	Modifica	—	SEC
	06 Gennaio 2020	—	Deposito iniziale	—	SEC
	23 Ottobre 2017	—	Deposito iniziale	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 37 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
BBC · ETFis Series Trust I	0,83%	74.799 NS	30 Aprile 2026	N-PORT
QQQS · Invesco Exchange-Traded Fund Trust …	0,82%	25.796 SH	08 Agosto 2026	Giornaliero
FYC · First Trust Exchange-Traded AlphaDE…	0,48%	1.206.971 NS	30 Aprile 2026	N-PORT
IWC · iShares Trust	0,30%	656.858 SH	08 Agosto 2026	Giornaliero
LABU · Direxion Shares ETF Trust	0,28%	343.575 NS	30 Aprile 2026	N-PORT
FYX · First Trust Exchange-Traded AlphaDE…	0,18%	538.178 NS	30 Aprile 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0,18%	19.403 SH	08 Agosto 2026	Giornaliero
FAD · First Trust Exchange-Traded AlphaDE…	0,10%	112.542 NS	30 Aprile 2026	N-PORT
IBB · iShares Trust	0,08%	1.154.248 SH	08 Agosto 2026	Giornaliero
IWO · iShares Trust	0,08%	1.738.974 SH	08 Agosto 2026	Giornaliero
VFMO · VANGUARD WELLINGTON FUND	0,08%	292.277 SH	08 Agosto 2026	Giornaliero
BIB · ProShares Trust	0,08%	13.080 NS	31 Maggio 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,06%	206.995 SH	08 Agosto 2026	Giornaliero
IWM · iShares Trust	0,04%	4.900.839 SH	08 Agosto 2026	Giornaliero
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,04%	71.286 NS	30 Aprile 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,03%	1.111.545 SH	08 Agosto 2026	Giornaliero
GSSC · Goldman Sachs ETF Trust	0,03%	65.610 NS	31 Maggio 2026	N-PORT
ISCV · iShares Trust	0,03%	25.549 SH	08 Agosto 2026	Giornaliero
RSSL · Global X Funds	0,02%	78.008 NS	30 Aprile 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,02%	585.833 SH	08 Agosto 2026	Giornaliero
ITWO · ProShares Trust	0,02%	8.486 NS	31 Maggio 2026	N-PORT
ISCB · iShares Trust	0,02%	8.008 SH	08 Agosto 2026	Giornaliero
SCHA · SCHWAB STRATEGIC TRUST	0,02%	839.393 NS	31 Maggio 2026	N-PORT
ISCG · iShares Trust	0,02%	22.039 SH	08 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,01%	81.104 NS	30 Aprile 2026	N-PORT
UWM · ProShares Trust	0,01%	6.636 NS	31 Maggio 2026	N-PORT
WSML · iShares Trust	0,01%	10.653 SH	08 Agosto 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,01%	2.042.450 SH	08 Agosto 2026	Giornaliero
URTY · ProShares Trust	0,01%	6.714 NS	31 Maggio 2026	N-PORT
ONEQ · Fidelity Commonwealth Trust	0,01%	126.693 NS	31 Maggio 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,00%	6.924 NS	31 Maggio 2026	N-PORT
HDG · ProShares Trust	0,00%	168 NS	31 Maggio 2026	N-PORT
IWV · iShares Trust	0,00%	61.530 SH	08 Agosto 2026	Giornaliero
ITOT · iShares Trust	0,00%	286.791 SH	08 Agosto 2026	Giornaliero
SCHB · SCHWAB STRATEGIC TRUST	0,00%	108.070 NS	31 Maggio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	5.690.796 SH	08 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	14.522 SH	08 Agosto 2026	Giornaliero

Informazioni su Precigen, Inc. - Common Stock Panoramica della società da Wikipedia

PGEN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

PGEN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

PGEN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 234 filer · $661.7M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 37 insider · 12 dirigenti · 10 direttori

Attivisti e proprietari del 5%+ 3 partecipazioni

Proprietà ETF Posseduti da 37 ETF